Global Preclinical Respiration and Inhalation Lab Equipment Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	158 Pages	TechNavio	January, 2024	INF18436675

Best Price Guarantee
Price	from $2,500
Length	158 Pages
Publisher	TechNavio
Published Date	January, 2024
SKU	INF18436675

Global Preclinical Respiration And Inhalation Lab Equipment Market 2024-2028

The preclinical respiration and inhalation lab equipment market is forecasted to grow by USD 4.16 bn during 2023-2028, accelerating at a CAGR of 4.29% during the forecast period. The report on the preclinical respiration and inhalation lab equipment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in research on respiratory diseases, growing prevalence of respiratory disorders, and high demand for CPAP devices among households.

Technavio's preclinical respiration and inhalation lab equipment market is segmented as below:

By Type

Respiration equipment
Inhalation equipment

By End-user

CROs and academic institutes
Pharma and biotech companies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advancements and increasing awareness of plethysmographs as one of the prime reasons driving the preclinical respiration and inhalation lab equipment market growth during the next few years. Also, growing popularity of minimally invasive techniques in respiratory research and significant development and growth in spirometers will lead to sizable demand in the market.

The report on the preclinical respiration and inhalation lab equipment market covers the following areas:

Preclinical respiration and inhalation lab equipment market sizing
Preclinical respiration and inhalation lab equipment market forecast
Preclinical respiration and inhalation lab equipment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical respiration and inhalation lab equipment market vendors that include 4DMedical Ltd, ADInstruments Pty Ltd., Bruker Corp., CH Technologies USA Inc., Columbus Instruments LLC, CWE, emka TECHNOLOGIES, EMMS, Harvard Bioscience Inc., IN TOX PRODUCTS LLC, Kent Scientific Corp., Koninklijke Philips N.V., Lab Products Inc., NuAire Inc., TSE Systems GmbH, Vivotecnia, and RWD Life Science Co. Ltd.. Also, the preclinical respiration and inhalation lab equipment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Type; Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global preclinical respiration and inhalation lab equipment market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global preclinical respiration and inhalation lab equipment market 2018 - 2022 ($ billion); 4.2 Type Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion); 4.3 End-user Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 30: Chart on Type - Market share 2023-2028 (%); Exhibit 31: Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Exhibit 32: Chart on Comparison by Type; Exhibit 33: Data Table on Comparison by Type; 6.3 Respiration equipment - Market size and forecast 2023-2028; Exhibit 34: Chart on Respiration equipment - Market size and forecast 2023-2028 ($ billion); Exhibit 35: Data Table on Respiration equipment - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Chart on Respiration equipment - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Respiration equipment - Year-over-year growth 2023-2028 (%); 6.4 Inhalation equipment - Market size and forecast 2023-2028; Exhibit 38: Chart on Inhalation equipment - Market size and forecast 2023-2028 ($ billion); Exhibit 39: Data Table on Inhalation equipment - Market size and forecast 2023-2028 ($ billion); Exhibit 40: Chart on Inhalation equipment - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Inhalation equipment - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Type; Exhibit 42: Market opportunity by Type ($ billion); Exhibit 43: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by End-user: 7.1 Market segments; Exhibit 44: Chart on End-user - Market share 2023-2028 (%); Exhibit 45: Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Exhibit 46: Chart on Comparison by End-user; Exhibit 47: Data Table on Comparison by End-user; 7.3 CROs and academic institutes - Market size and forecast 2023-2028; Exhibit 48: Chart on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion); Exhibit 49: Data Table on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion); Exhibit 50: Chart on CROs and academic institutes - Year-over-year growth 2023-2028 (%); Exhibit 51: Data Table on CROs and academic institutes - Year-over-year growth 2023-2028 (%); 7.4 Pharma and biotech companies - Market size and forecast 2023-2028; Exhibit 52: Chart on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion); Exhibit 53: Data Table on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion); Exhibit 54: Chart on Pharma and biotech companies - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Pharma and biotech companies - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by End-user; Exhibit 56: Market opportunity by End-user ($ billion); Exhibit 57: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 61: Chart on Geographic comparison; Exhibit 62: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 France - Market size and forecast 2023-2028; Exhibit 87: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibit 88: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibit 89: Chart on France - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on France - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 99: Market opportunity By Geographical Landscape ($ billion); Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 101: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 102: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 103: Overview on factors of disruption; 11.4 Industry risks; Exhibit 104: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 105: Vendors covered; 12.2 Market positioning of vendors; Exhibit 106: Matrix on vendor position and classification; 12.3 4DMedical Ltd; Exhibit 107: 4DMedical Ltd - Overview; Exhibit 108: 4DMedical Ltd - Product / Service; Exhibit 109: 4DMedical Ltd - Key offerings; 12.4 ADInstruments Pty Ltd.; Exhibit 110: ADInstruments Pty Ltd. - Overview; Exhibit 111: ADInstruments Pty Ltd. - Product / Service; Exhibit 112: ADInstruments Pty Ltd. - Key offerings; 12.5 Bruker Corp.; Exhibit 113: Bruker Corp. - Overview; Exhibit 114: Bruker Corp. - Business segments; Exhibit 115: Bruker Corp. - Key offerings; Exhibit 116: Bruker Corp. - Segment focus; 12.6 CH Technologies USA Inc.; Exhibit 117: CH Technologies USA Inc. - Overview; Exhibit 118: CH Technologies USA Inc. - Product / Service; Exhibit 119: CH Technologies USA Inc. - Key offerings; 12.7 Columbus Instruments LLC; Exhibit 120: Columbus Instruments LLC - Overview; Exhibit 121: Columbus Instruments LLC - Product / Service; Exhibit 122: Columbus Instruments LLC - Key offerings; 12.8 CWE; Exhibit 123: CWE - Overview; Exhibit 124: CWE - Product / Service; Exhibit 125: CWE - Key offerings; 12.9 emka TECHNOLOGIES; Exhibit 126: emka TECHNOLOGIES - Overview; Exhibit 127: emka TECHNOLOGIES - Product / Service; Exhibit 128: emka TECHNOLOGIES - Key offerings; 12.10 EMMS; Exhibit 129: EMMS - Overview; Exhibit 130: EMMS - Product / Service; Exhibit 131: EMMS - Key offerings; 12.11 Harvard Bioscience Inc.; Exhibit 132: Harvard Bioscience Inc. - Overview; Exhibit 133: Harvard Bioscience Inc. - Product / Service; Exhibit 134: Harvard Bioscience Inc. - Key offerings; 12.12 IN TOX PRODUCTS LLC; Exhibit 135: IN TOX PRODUCTS LLC - Overview; Exhibit 136: IN TOX PRODUCTS LLC - Product / Service; Exhibit 137: IN TOX PRODUCTS LLC - Key offerings; 12.13 Kent Scientific Corp.; Exhibit 138: Kent Scientific Corp. - Overview; Exhibit 139: Kent Scientific Corp. - Key offerings; 12.14 Lab Products Inc.; Exhibit 140: Lab Products Inc. - Overview; Exhibit 141: Lab Products Inc. - Product / Service; Exhibit 142: Lab Products Inc. - Key offerings; 12.15 NuAire Inc.; Exhibit 143: NuAire Inc. - Overview; Exhibit 144: NuAire Inc. - Product / Service; Exhibit 145: NuAire Inc. - Key offerings; 12.16 RWD Life Science Co. Ltd.; Exhibit 146: RWD Life Science Co. Ltd. - Overview; Exhibit 147: RWD Life Science Co. Ltd. - Product / Service; Exhibit 148: RWD Life Science Co. Ltd. - Key offerings; 12.17 TSE Systems GmbH; Exhibit 149: TSE Systems GmbH - Overview; Exhibit 150: TSE Systems GmbH - Product / Service; Exhibit 151: TSE Systems GmbH - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 152: Inclusions checklist; Exhibit 153: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 154: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 155: Research methodology; Exhibit 156: Validation techniques employed for market sizing; Exhibit 157: Information sources; 13.5 List of abbreviations; Exhibit 158: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global preclinical respiration and inhalation lab equipment market 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Type - Market share 2023-2028 (%); Exhibits31: Data Table on Type - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Type; Exhibits33: Data Table on Comparison by Type; Exhibits34: Chart on Respiration equipment - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on Respiration equipment - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on Respiration equipment - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Respiration equipment - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Inhalation equipment - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Inhalation equipment - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Inhalation equipment - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Inhalation equipment - Year-over-year growth 2023-2028 (%); Exhibits42: Market opportunity by Type ($ billion); Exhibits43: Data Table on Market opportunity by Type ($ billion); Exhibits44: Chart on End-user - Market share 2023-2028 (%); Exhibits45: Data Table on End-user - Market share 2023-2028 (%); Exhibits46: Chart on Comparison by End-user; Exhibits47: Data Table on Comparison by End-user; Exhibits48: Chart on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion); Exhibits49: Data Table on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion); Exhibits50: Chart on CROs and academic institutes - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on CROs and academic institutes - Year-over-year growth 2023-2028 (%); Exhibits52: Chart on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Pharma and biotech companies - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Pharma and biotech companies - Year-over-year growth 2023-2028 (%); Exhibits56: Market opportunity by End-user ($ billion); Exhibits57: Data Table on Market opportunity by End-user ($ billion); Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits61: Chart on Geographic comparison; Exhibits62: Data Table on Geographic comparison; Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibits88: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibits89: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits99: Market opportunity By Geographical Landscape ($ billion); Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits101: Impact of drivers and challenges in 2023 and 2028; Exhibits102: Overview on Criticality of inputs and Factors of differentiation; Exhibits103: Overview on factors of disruption; Exhibits104: Impact of key risks on business; Exhibits105: Vendors covered; Exhibits106: Matrix on vendor position and classification; Exhibits107: 4DMedical Ltd - Overview; Exhibits108: 4DMedical Ltd - Product / Service; Exhibits109: 4DMedical Ltd - Key offerings; Exhibits110: ADInstruments Pty Ltd. - Overview; Exhibits111: ADInstruments Pty Ltd. - Product / Service; Exhibits112: ADInstruments Pty Ltd. - Key offerings; Exhibits113: Bruker Corp. - Overview; Exhibits114: Bruker Corp. - Business segments; Exhibits115: Bruker Corp. - Key offerings; Exhibits116: Bruker Corp. - Segment focus; Exhibits117: CH Technologies USA Inc. - Overview; Exhibits118: CH Technologies USA Inc. - Product / Service; Exhibits119: CH Technologies USA Inc. - Key offerings; Exhibits120: Columbus Instruments LLC - Overview; Exhibits121: Columbus Instruments LLC - Product / Service; Exhibits122: Columbus Instruments LLC - Key offerings; Exhibits123: CWE - Overview; Exhibits124: CWE - Product / Service; Exhibits125: CWE - Key offerings; Exhibits126: emka TECHNOLOGIES - Overview; Exhibits127: emka TECHNOLOGIES - Product / Service; Exhibits128: emka TECHNOLOGIES - Key offerings; Exhibits129: EMMS - Overview; Exhibits130: EMMS - Product / Service; Exhibits131: EMMS - Key offerings; Exhibits132: Harvard Bioscience Inc. - Overview; Exhibits133: Harvard Bioscience Inc. - Product / Service; Exhibits134: Harvard Bioscience Inc. - Key offerings; Exhibits135: IN TOX PRODUCTS LLC - Overview; Exhibits136: IN TOX PRODUCTS LLC - Product / Service; Exhibits137: IN TOX PRODUCTS LLC - Key offerings; Exhibits138: Kent Scientific Corp. - Overview; Exhibits139: Kent Scientific Corp. - Key offerings; Exhibits140: Lab Products Inc. - Overview; Exhibits141: Lab Products Inc. - Product / Service; Exhibits142: Lab Products Inc. - Key offerings; Exhibits143: NuAire Inc. - Overview; Exhibits144: NuAire Inc. - Product / Service; Exhibits145: NuAire Inc. - Key offerings; Exhibits146: RWD Life Science Co. Ltd. - Overview; Exhibits147: RWD Life Science Co. Ltd. - Product / Service; Exhibits148: RWD Life Science Co. Ltd. - Key offerings; Exhibits149: TSE Systems GmbH - Overview; Exhibits150: TSE Systems GmbH - Product / Service; Exhibits151: TSE Systems GmbH - Key offerings; Exhibits152: Inclusions checklist; Exhibits153: Exclusions checklist; Exhibits154: Currency conversion rates for US$; Exhibits155: Research methodology; Exhibits156: Validation techniques employed for market sizing; Exhibits157: Information sources; Exhibits158: List of abbreviations